|
alzheimer disease |
3 |
|
amyloid beta-peptides |
3 |
|
animals |
3 |
|
design of experiment |
3 |
|
dry powder |
3 |
|
early diagnosis |
3 |
|
human serum albumin |
3 |
|
magnetic resonance imaging |
3 |
|
nanoparticles |
3 |
|
pharmacokinetics |
3 |
|
pulmonary delivery |
3 |
|
pulmonary drug delivery |
3 |
|
small interfering rna |
3 |
|
antifungal |
2 |
|
continuous manufacturing |
2 |
|
curcumin |
2 |
|
dry powder inhaler |
2 |
|
factorial design |
2 |
|
flash nanoprecipitation |
2 |
|
gene silencing |
2 |
|
in vitro/in vivo (ivivc) correlation(s) |
2 |
|
nanoagglomerate |
2 |
|
nanomedicine |
2 |
|
next generation impactor |
2 |
|
particle size |
2 |
|
physical stability |
2 |
|
remdesivir |
2 |
|
sirna |
2 |
|
site-specific delivery |
2 |
|
spray freeze drying |
2 |
|
stability |
2 |
|
voriconazole |
2 |
|
x-ray photoelectron spectroscopy |
2 |
|
active pharmaceutical ingredients |
1 |
|
alzheimer's disease |
1 |
|
amorphization technologies |
1 |
|
amorphous solid dispersion |
1 |
|
amphiphilic stabilizers |
1 |
|
antisolvent nanoprecipitation |
1 |
|
antiviral cocrystal |
1 |
|
atomic force microscopy |
1 |
|
behavior tests |
1 |
|
berberine chloride hydrates |
1 |
|
brain delivery |
1 |
|
breast cancer |
1 |
|
buccal delivery |
1 |
|
centrifugal ultrafiltration |
1 |
|
cholesterol |
1 |
|
clearance mechanism |
1 |
|
co-stabilizer |
1 |
|
cocrystal dissociation |
1 |
|
cocrystal engineering |
1 |
|
cocrystal screening |
1 |
|
cocrystal solution-state stability |
1 |
|
confined impinging jets with dilution mixer |
1 |
|
confined impinging jets-with-dilution mixer |
1 |
|
curcumin nanoparticles |
1 |
|
delivery efficiency |
1 |
|
dialysis |
1 |
|
diffusion |
1 |
|
dissolution |
1 |
|
drug release |
1 |
|
drug-drug cocrystal |
1 |
|
drying kinetics |
1 |
|
filtration |
1 |
|
gelation |
1 |
|
glass transition |
1 |
|
ibuprofen |
1 |
|
in vitro release kinetics |
1 |
|
in-vitro anticancer activity |
1 |
|
inhalable and redispersible nano-agglomerates |
1 |
|
inhalable cocrystal |
1 |
|
itraconazole |
1 |
|
itraconazole nanoparticles |
1 |
|
lyophilization |
1 |
|
microfluidic mixer device |
1 |
|
mixing |
1 |
|
molecular mobility |
1 |
|
molecular reorientation |
1 |
|
multi-inlet vortex mixer |
1 |
|
multi-inlet vortex mixer (mivm) |
1 |
|
nanocurcumin |
1 |
|
nanoparticle |
1 |
|
nanoparticle agglomerate |
1 |
|
nanoparticle stability |
1 |
|
ocular barriers |
1 |
|
ocular delivery |
1 |
|
oral drug delivery |
1 |
|
oral mucosal delivery |
1 |
|
oral route |
1 |
|
orally-dissolving films |
1 |
|
paclitaxel |
1 |
|
parkinson's disease |
1 |
|
peg-b-pcl |
1 |
|
pharmaceutical cocrystal |
1 |
|
pharmacokinetic |
1 |
|
phase transformation |
1 |
|
physical instability |
1 |
|
physicochemical properties |
1 |
|
polymer carrier |
1 |
|
polymeric micelles |
1 |
|
polymeric nanoparticle |
1 |
|
polymeric nanoparticles |
1 |
|
polymorphism |
1 |
|
poorly water-soluble drug |
1 |
|
reformulation |
1 |
|
retinal diseases |
1 |
|
ropinirole |
1 |
|
solid-state transition |
1 |
|
solubility |
1 |
|
solubility parameter |
1 |
|
spray drying |
1 |
|
sublingual delivery |
1 |
|
supersaturation |
1 |
|
surface analysis |
1 |
|
traditional chinese medicine |
1 |
|
ursolic acid |
1 |
|
wet granulation |
1 |
